François-Clément Bidard
Institut Curie
4
4
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mothaffar Rimawi, MD
Baylor College of Medicine
Shared therapeutic areas:
Jonathan McConathy, MD, PhD
University of Alabama at Birmingham
Shared therapeutic areas:
REGIS SOUCHE
University Hospital, Montpellier
Shared therapeutic areas:
Kari Wisinski, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Lillian Siu, MD
Princess Margaret Hospital, Canada
Shared therapeutic areas:
Fei Ma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Zhong-yu Yuan, M.D.
Sun Yat-sen University
Shared therapeutic areas:
Priyanka Sharma, MD
University of Kansas Medical Center
Shared therapeutic areas:
Jacob Lalezari, MD
CytoDyn, Inc.
Shared therapeutic areas:
Mark Jones, MD
Incyte Corporation
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
All 4 trials loaded